STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study
Circulation: Arrhythmia and Electrophysiology · 2025
DOI: 10.1161/circep.124.013684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025. Verfasst von Brian Zenger und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cardiovascular Division (B.Z., T.W.S., S.H., S.N., J.T., S.D.J., A.K., S.M., A.J., P.S.C., S.L.R.), Washington Unive…. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Stereotaxic Techniques, Radiotherapy, Myocardial Infarction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Stereotactic arrhythmia radiotherapy (STAR) has emerged as a potential therapy for treatment-refractory ventricular tachycardia (VT). However, the mechanisms underlying STAR efficacy, such as scar or other electromechanical changes, are still unclear. The goal of this study was to develop a translational porcine model of ischemic monomorphic VT treated with STAR to examine the physiological changes after a typical clinical STAR treatment. METHODS: We treated a previously validated porcine model of monomorphic VT after myocardial infarction with a clinically derived STAR protocol. A dose of 25 Gy was prescribed to the planning target volume and 35 Gy to the clinical target volume (regions of scar), while controls underwent a sham STAR treatment. All investigators in the study were blinded except the treating investigator. The primary study outcome was VT inducibility at 6 weeks post-STAR. Animals underwent pre- and post-STAR cardiac magnetic resonance imaging to quantify myocardial scar and function, as well as body surface mapping. Six weeks post-STAR, animals underwent a VT induction study, and tissue was harvested for optical mapping and histological analysis. RESULTS: Six animals completed the study, which ended before finishing enrollment because all animals had inducible VT. We found a significantly longer local effective refractory period in the left ventricular apex and longer VT cycle lengths in STAR-treated animals compared with controls ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Cardiovascular Division (B.Z., T.W.S., S.H., S.N., J.T., S.D.J., A.K., S.M., A.J., P.S.C., S.L.R.), Washington University School of Medicine, St. Louis, MO.
- Center for Noninvasive Cardiac Radiotherapy (B.Z., T.W.S., S.H., S.N., N.K., P.P.S., J.T., S.D.J., L.M., A.K., S.M., A.J., C. Bergom, J.K.S., G.D.H., P.S.C., C.R., S.L.R.), Washington University School of Medicine, St.…
- Division of Comparative Medicine (T.P., L.D.W.), Washington University School of Medicine, St. Louis, MO.
- Department of Radiation Oncology (N.K., P.P.S., L.C.M., C. Bergom, J.K.S., G.D.H., C.R.), Washington University School of Medicine, St. Louis, MO.
- Department of Radiology (J.Z., C. Berberet), Washington University School of Medicine, St. Louis, MO.
- Department of Biomedical Engineering, Medical College of Wisconsin, Milwaukee (E.-S.H.I.).
ORCID-Profile: Brian Zenger, Timothy W Smith, Sherwin Ng, Todd Pavek, Jie Zheng, Caleb Berberet, Vinay Jani, James Tabor, Leslie D Wilson, Samuel D Jordan, Sneha Manikandan, Ali Javaheri, Carmen Bergom, Julie K Schwarz, Patrick M Boyle, Geoffrey D Hugo, Cliff Robinson, Christian Zemlin, Stacey L Rentschler
Förderung
- NHLBI NIH HHS
- NIH HHS
Zitieren
APA
Zenger, B., Smith, T. W., Hicks, S., Ng, S., Pavek, T., Knutson, N., Samson, P. P., Zheng, J., Berberet, C., Ibrahim, E. H., Jani, V., Tabor, J., Wilson, L. D., Jordan, S. D., Marut, L. C., Kumar, A., Manikandan, S., Javaheri, A., Bergom, C., …, & Rentschler, S. L. (2025). STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.124.013684
Vancouver
Zenger B, Smith TW, Hicks S, Ng S, Pavek T, Knutson N, et al. STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study. Circulation: Arrhythmia and Electrophysiology. 2025. doi:10.1161/circep.124.013684
BibTeX
@article{Zenger2025,
author = {Zenger, Brian and Smith, Timothy W and Hicks, Stephanie and Ng, Sherwin and Pavek, Todd and Knutson, Nels and Samson, Pamela P and Zheng, Jie and Berberet, Caleb and Ibrahim, El-Sayed H and Jani, Vinay and Tabor, James and Wilson, Leslie D and Jordan, Samuel D and Marut, Luke C and Kumar, Aryan and Manikandan, Sneha and Javaheri, Ali and Bergom, Carmen and Schwarz, Julie K and Boyle, Patrick M and Hugo, Geoffrey D and Cuculich, Phillip S and Robinson, Cliff and Zemlin, Christian and Rentschler, Stacey L},
title = {STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model Study},
journal = {Circulation: Arrhythmia and Electrophysiology},
year = {2025},
doi = {10.1161/circep.124.013684}
}
EUVIMED